Description
Genomic Health 09-060: A real-world observational study to provide prospective information on the management of patients with metastatic castration-resistant prostate cancer (mCRPC) with disease progression after at least one line of androgen receptor-targeted therapy (ARTT) and the use of the Oncotype DX AR-V7 Nucleus Detect® assay in subsequent management
Principal Investigator
Co-Investigator(s)
Kristin N. Arreola, M.D., Sivakumar Reddy, M.D., Nitin Rohatgi, MD, Brian K. Kim, M.D, Vijay Suhag, M.D., Rajeswari Chellappah, M.D., Kristie A. Bobolis, M.D.